Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells

Jean-Baptiste Roullet, Ulrich C. Luft, Hong Xue, Justin Chapman, Rostislav Bychkov, Chantal M. Roullet, Friedrich C. Luft, Hermann Haller, David A. McCarron

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoconstriction (Roullet, J.B., Xue, H., Chapman, J., McDougal, P., Roullet, C. M., and McCarron, D. A. (1996) J. Clin. Invest. 97, 2364-2390). We report here that farnesol reduced KCl- and norepinephrine-dependent cytosolic Ca2+ transients in fura-2-loaded intact arteries. An effect on Ca2+ signaling was also observed in cultured aortic smooth muscle cells (A10 cells). In these cells, farnesol reduced KCl-induced [Ca2+](i) transients and mimicked the inhibitory effect of Ca2+-free medium on the [Ca2+](i) response to both 12,13-phorbol myristate acetate, a protein kinase C activator, and thapsigargin, a specific endoplasmic reticulum ATPase inhibitor. Perforated patch-clamp experiments further showed in two vascular smooth muscle cell lines (A10 and A7r5), a reversible, dose-dependent inhibitory effect of farnesol on L-type Ca2+ currents (IC50 = 2.2μM). Shorter (C10, geraniol) and longer (C20, geranylgeraniol) isoprenols were inactive. L- type Ca2+ channel blockade also occurred under tight (gigaohm) seal configuration using cell-attached, single-channel analysis, thus suggesting a possible action of farnesol from within the intracellular space. We finally demonstrated that farnesol did not affect Ca2+-sensitive pathways implicated in smooth muscle contraction, as tested with α-toxin permeabilized arteries. Altogether, our results indicate that farnesol is an inhibitor of vascular smooth muscle Ca2+ signaling with plasma membrane Ca2+ channel blocker properties. The data have implications for the endogenous and pharmacological regulation of vascular tone by farnesol or farnesol analogues.

Original languageEnglish (US)
Pages (from-to)32240-32246
Number of pages7
JournalJournal of Biological Chemistry
Volume272
Issue number51
DOIs
StatePublished - Dec 19 1997

Fingerprint

Farnesol
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Cells
Arteries
antineoplaston A10
Intracellular Space
Thapsigargin
Fura-2
Terpenes
Clamping devices
Tetradecanoylphorbol Acetate
Cell membranes
Muscle Contraction
Vasoconstriction
Ion Channels
Endoplasmic Reticulum
Protein Kinase C
Inhibitory Concentration 50

ASJC Scopus subject areas

  • Biochemistry

Cite this

Roullet, J-B., Luft, U. C., Xue, H., Chapman, J., Bychkov, R., Roullet, C. M., ... McCarron, D. A. (1997). Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells. Journal of Biological Chemistry, 272(51), 32240-32246. https://doi.org/10.1074/jbc.272.51.32240

Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells. / Roullet, Jean-Baptiste; Luft, Ulrich C.; Xue, Hong; Chapman, Justin; Bychkov, Rostislav; Roullet, Chantal M.; Luft, Friedrich C.; Haller, Hermann; McCarron, David A.

In: Journal of Biological Chemistry, Vol. 272, No. 51, 19.12.1997, p. 32240-32246.

Research output: Contribution to journalArticle

Roullet, J-B, Luft, UC, Xue, H, Chapman, J, Bychkov, R, Roullet, CM, Luft, FC, Haller, H & McCarron, DA 1997, 'Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells', Journal of Biological Chemistry, vol. 272, no. 51, pp. 32240-32246. https://doi.org/10.1074/jbc.272.51.32240
Roullet J-B, Luft UC, Xue H, Chapman J, Bychkov R, Roullet CM et al. Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells. Journal of Biological Chemistry. 1997 Dec 19;272(51):32240-32246. https://doi.org/10.1074/jbc.272.51.32240
Roullet, Jean-Baptiste ; Luft, Ulrich C. ; Xue, Hong ; Chapman, Justin ; Bychkov, Rostislav ; Roullet, Chantal M. ; Luft, Friedrich C. ; Haller, Hermann ; McCarron, David A. / Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 51. pp. 32240-32246.
@article{47efa5481d1c4119ab89969ae279bf00,
title = "Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells",
abstract = "Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoconstriction (Roullet, J.B., Xue, H., Chapman, J., McDougal, P., Roullet, C. M., and McCarron, D. A. (1996) J. Clin. Invest. 97, 2364-2390). We report here that farnesol reduced KCl- and norepinephrine-dependent cytosolic Ca2+ transients in fura-2-loaded intact arteries. An effect on Ca2+ signaling was also observed in cultured aortic smooth muscle cells (A10 cells). In these cells, farnesol reduced KCl-induced [Ca2+](i) transients and mimicked the inhibitory effect of Ca2+-free medium on the [Ca2+](i) response to both 12,13-phorbol myristate acetate, a protein kinase C activator, and thapsigargin, a specific endoplasmic reticulum ATPase inhibitor. Perforated patch-clamp experiments further showed in two vascular smooth muscle cell lines (A10 and A7r5), a reversible, dose-dependent inhibitory effect of farnesol on L-type Ca2+ currents (IC50 = 2.2μM). Shorter (C10, geraniol) and longer (C20, geranylgeraniol) isoprenols were inactive. L- type Ca2+ channel blockade also occurred under tight (gigaohm) seal configuration using cell-attached, single-channel analysis, thus suggesting a possible action of farnesol from within the intracellular space. We finally demonstrated that farnesol did not affect Ca2+-sensitive pathways implicated in smooth muscle contraction, as tested with α-toxin permeabilized arteries. Altogether, our results indicate that farnesol is an inhibitor of vascular smooth muscle Ca2+ signaling with plasma membrane Ca2+ channel blocker properties. The data have implications for the endogenous and pharmacological regulation of vascular tone by farnesol or farnesol analogues.",
author = "Jean-Baptiste Roullet and Luft, {Ulrich C.} and Hong Xue and Justin Chapman and Rostislav Bychkov and Roullet, {Chantal M.} and Luft, {Friedrich C.} and Hermann Haller and McCarron, {David A.}",
year = "1997",
month = "12",
day = "19",
doi = "10.1074/jbc.272.51.32240",
language = "English (US)",
volume = "272",
pages = "32240--32246",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells

AU - Roullet, Jean-Baptiste

AU - Luft, Ulrich C.

AU - Xue, Hong

AU - Chapman, Justin

AU - Bychkov, Rostislav

AU - Roullet, Chantal M.

AU - Luft, Friedrich C.

AU - Haller, Hermann

AU - McCarron, David A.

PY - 1997/12/19

Y1 - 1997/12/19

N2 - Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoconstriction (Roullet, J.B., Xue, H., Chapman, J., McDougal, P., Roullet, C. M., and McCarron, D. A. (1996) J. Clin. Invest. 97, 2364-2390). We report here that farnesol reduced KCl- and norepinephrine-dependent cytosolic Ca2+ transients in fura-2-loaded intact arteries. An effect on Ca2+ signaling was also observed in cultured aortic smooth muscle cells (A10 cells). In these cells, farnesol reduced KCl-induced [Ca2+](i) transients and mimicked the inhibitory effect of Ca2+-free medium on the [Ca2+](i) response to both 12,13-phorbol myristate acetate, a protein kinase C activator, and thapsigargin, a specific endoplasmic reticulum ATPase inhibitor. Perforated patch-clamp experiments further showed in two vascular smooth muscle cell lines (A10 and A7r5), a reversible, dose-dependent inhibitory effect of farnesol on L-type Ca2+ currents (IC50 = 2.2μM). Shorter (C10, geraniol) and longer (C20, geranylgeraniol) isoprenols were inactive. L- type Ca2+ channel blockade also occurred under tight (gigaohm) seal configuration using cell-attached, single-channel analysis, thus suggesting a possible action of farnesol from within the intracellular space. We finally demonstrated that farnesol did not affect Ca2+-sensitive pathways implicated in smooth muscle contraction, as tested with α-toxin permeabilized arteries. Altogether, our results indicate that farnesol is an inhibitor of vascular smooth muscle Ca2+ signaling with plasma membrane Ca2+ channel blocker properties. The data have implications for the endogenous and pharmacological regulation of vascular tone by farnesol or farnesol analogues.

AB - Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoconstriction (Roullet, J.B., Xue, H., Chapman, J., McDougal, P., Roullet, C. M., and McCarron, D. A. (1996) J. Clin. Invest. 97, 2364-2390). We report here that farnesol reduced KCl- and norepinephrine-dependent cytosolic Ca2+ transients in fura-2-loaded intact arteries. An effect on Ca2+ signaling was also observed in cultured aortic smooth muscle cells (A10 cells). In these cells, farnesol reduced KCl-induced [Ca2+](i) transients and mimicked the inhibitory effect of Ca2+-free medium on the [Ca2+](i) response to both 12,13-phorbol myristate acetate, a protein kinase C activator, and thapsigargin, a specific endoplasmic reticulum ATPase inhibitor. Perforated patch-clamp experiments further showed in two vascular smooth muscle cell lines (A10 and A7r5), a reversible, dose-dependent inhibitory effect of farnesol on L-type Ca2+ currents (IC50 = 2.2μM). Shorter (C10, geraniol) and longer (C20, geranylgeraniol) isoprenols were inactive. L- type Ca2+ channel blockade also occurred under tight (gigaohm) seal configuration using cell-attached, single-channel analysis, thus suggesting a possible action of farnesol from within the intracellular space. We finally demonstrated that farnesol did not affect Ca2+-sensitive pathways implicated in smooth muscle contraction, as tested with α-toxin permeabilized arteries. Altogether, our results indicate that farnesol is an inhibitor of vascular smooth muscle Ca2+ signaling with plasma membrane Ca2+ channel blocker properties. The data have implications for the endogenous and pharmacological regulation of vascular tone by farnesol or farnesol analogues.

UR - http://www.scopus.com/inward/record.url?scp=0031466230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031466230&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.51.32240

DO - 10.1074/jbc.272.51.32240

M3 - Article

C2 - 9405427

AN - SCOPUS:0031466230

VL - 272

SP - 32240

EP - 32246

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -